Company Information

CIN
Status
Date of Incorporation
28 September 2011
State / ROC
Delhi / ROC Delhi
Last Balance Sheet
31 March 2015
Last Annual Meeting
30 September 2015
Paid Up Capital
100,000
Authorised Capital
300,000

Directors

Zafar Siddiqui
Zafar Siddiqui
Director/Designated Partner
over 9 years ago
Mohamad Islam
Mohamad Islam
Director/Designated Partner
about 10 years ago
Sanjay Kumar Mishra
Sanjay Kumar Mishra
Director
about 14 years ago

Past Directors

Lakshman Jha
Lakshman Jha
Director
almost 12 years ago

Registered Trademarks

Parcena(device) Clavis Pharma

[Class : 5] Pharmaceutical & Medicinal Preparations

Rzen Plus Clavis Pharma

[Class : 5] Pharmaceutical & Medicinal Preparations

Augxime(device) Clavis Pharma

[Class : 5] Pharmaceutical & Medicinal Preparations
View +2 more Brands for Clavis Pharma Private Limited.

Documents

Optional Attachment-(1)-10042017
Notice of resignation;-10042017
Form DIR-12-10042017_signed
Evidence of cessation;-10042017
Proof of dispatch-08042017
Notice of resignation filed with the company-08042017
Form DIR-11-08042017_signed
Acknowledgement received from company-08042017
Acknowledgement received from company-19072016
Declaration of the appointee director, Managing director, in Form No. DIR-2;-19072016
Evidence of cessation;-19072016
Form DIR-11-19072016_signed
Form DIR-12-19072016_signed
Letter of appointment;-19072016
Notice of resignation filed with the company-19072016
Notice of resignation;-19072016
Proof of dispatch-19072016
Form INC-22-16072016_signed
Proof of Registered Office address(Conveyance/Lease deed/Rent Agreement along with the rent receipts) etc-16072016
Optional Attachment-(1)-16072016
Copy of board resolution authorizing giving of notice-16072016
Copies of the utility bills as mentioned above (not older than two months)-16072016
Form AOC-4-131215.OCT
Form MGT-7-021215.OCT
Form DIR-12-211115.OCT
Letter of Appointment-201115.PDF
Declaration of the appointee Director- in Form DIR-2-201115.PDF
Form23AC-240914 for the FY ending on-310314.OCT
FormSchV-240914 for the FY ending on-310314.OCT
Form MGT-14-290714.OCT